Ethyl Chloride Vapocoolant as Anesthesia for Arterial Punctures

Sponsor
Bionorte (Other)
Overall Status
Completed
CT.gov ID
NCT02587143
Collaborator
Osakidetza (Other), University of the Basque Country (UPV/EHU) (Other)
126
1
2
11
11.4

Study Details

Study Description

Brief Summary

Ethyl chloride vapocoolant sprays provide transient skin anesthesia within seconds of application. The current investigation aim is to compare the effect of ethyl chloride based vapocoolant spray to placebo in reducing pain associated with arterial puncture for gasometry determinations.

The investigators will conduce a double-blind randomized placebo-controlled trial at Emergency Department.

We will enroll patients who come to Emergency Department who need an arterial gasometry determination. Patients will be randomized to intervention-group (ethyl chloride vapocoolant sprays will be usad before arterial puncture) or to placebo-group (alcohol spray as placebo will be used before arterial puncture.) and after the puncture they will rate their pain using a 10 points visual analogue scale.

Condition or Disease Intervention/Treatment Phase
N/A

Detailed Description

Single-blind, randomized placebo-controlled trial in an emergency department of Hospital de Basurto in Bilbao, Spain. Patients for whom arterial blood gas analysis had been ordered will be included. They will be randomly assigned to receive application of the experimental ethyl chloride spray or a placebo aerosol spray of a solution of alcohol in water. The assigned spray will be applied just before arterial puncture. The main outcome variable is pain intensity reported on an 11-point numeric rating scale.

Study Design

Study Type:
Interventional
Actual Enrollment :
126 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Official Title:
Ethyl Chloride Vapocoolant as Anesthesia for Arterial Punctures: A Randomized Clinical Trial
Actual Study Start Date :
Feb 1, 2016
Actual Primary Completion Date :
Jan 1, 2017
Actual Study Completion Date :
Jan 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Control

Alcohol -based spray as placebo will be administrated before arterial puncture.

Drug: Alcohol
Nurses will use an alcohol-based spray as placebo on patient's skin a few seconds before arterial puncture (of cubital arteria).
Other Names:
  • Placebo
  • Experimental: Ethyl chloride

    Ethyl choride will be administrated before arterial puncture.

    Drug: Ethyl chloride
    Nurses will administrate ethyl chloride vapocoolant spray on patient's skin a few seconds before arterial puncture (of cubital arteria).
    Other Names:
  • Intervention
  • Outcome Measures

    Primary Outcome Measures

    1. Pain Level on the Visual Analog Scale (NRS-11) [scores on a scale immediately after the puncture]

      patients will measure their pain score on a visual analog scale (NRS-11: Numeric Rate Score, from 0 -no pain- to 10 points -the worst pain ever-) after the puncture

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 85 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • age: 18-85 years old.

    • arterial gasometry determination needed

    • III, IV or V level classification on Manchester triage.

    Exclusion criteria:
    • refusal to participate,

    • inability to provide informed consent (non-Spanish speaking, dementia or altered mental state),

    • skin disease associated with cold intolerance (Raynaud's phenomenon),

    • known allergy to spray contents,

    • Glasgow Coma Scale <15,

    • pregnancy,

    • under effects of alcohol or drugs,

    • Allen test +.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hospital de Basurto Bilbao Bizkaia Spain

    Sponsors and Collaborators

    • Bionorte
    • Osakidetza
    • University of the Basque Country (UPV/EHU)

    Investigators

    • Principal Investigator: SENDOA BALLESTEROS-PEÑA, PhD, HOSPITAL OF BASURTO (BILBAO)

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    SENDOA BALLESTEROS-PEÑA, Emergency nurse practitioner, PhD doctor., Bionorte
    ClinicalTrials.gov Identifier:
    NCT02587143
    Other Study ID Numbers:
    • GASOHUB
    First Posted:
    Oct 27, 2015
    Last Update Posted:
    Jan 22, 2020
    Last Verified:
    Jan 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Additional relevant MeSH terms:

    Study Results

    Participant Flow

    Recruitment Details
    Pre-assignment Detail Seccondary effcts happens after punctre (dizziness...)
    Arm/Group Title Ethyl Chloride Control
    Arm/Group Description Ethyl choride will be administrated before arterial puncture. Ethyl chloride: Nurses will administrate ethyl chloride vapocoolant spray on patient's skin a few seconds before arterial puncture. Alcohol -based spray as placebo will be administrated before arterial puncture. Alcohol: Nurses will use an alcohol-based spray as placebo on patient's skin a few seconds before arterial puncture.
    Period Title: Overall Study
    STARTED 66 60
    COMPLETED 65 60
    NOT COMPLETED 1 0

    Baseline Characteristics

    Arm/Group Title Control Ethyl Chloride Total
    Arm/Group Description Alcohol -based spray as placebo will be administrated before arterial puncture. Alcohol: Nurses will use an alcohol-based spray as placebo on patient's skin a few seconds before arterial puncture. Ethyl choride will be administrated before arterial puncture. Ethyl chloride: Nurses will administrate ethyl chloride vapocoolant spray on patient's skin a few seconds before arterial puncture. Total of all reporting groups
    Overall Participants 60 66 126
    Age (years) [Mean (Standard Deviation) ]
    Mean (Standard Deviation) [years]
    68.7
    (12.1)
    67.1
    (14.4)
    67.9
    (13.3)
    Sex: Female, Male (Count of Participants)
    Female
    22
    36.7%
    25
    37.9%
    47
    37.3%
    Male
    38
    63.3%
    41
    62.1%
    79
    62.7%
    Arteria of puncture (Count of Participants)
    Cubital arteria
    50
    83.3%
    56
    84.8%
    106
    84.1%
    Humeral arteria
    10
    16.7%
    10
    15.2%
    20
    15.9%

    Outcome Measures

    1. Primary Outcome
    Title Pain Level on the Visual Analog Scale (NRS-11)
    Description patients will measure their pain score on a visual analog scale (NRS-11: Numeric Rate Score, from 0 -no pain- to 10 points -the worst pain ever-) after the puncture
    Time Frame scores on a scale immediately after the puncture

    Outcome Measure Data

    Analysis Population Description
    [Not Specified]
    Arm/Group Title Control Ethyl Chloride
    Arm/Group Description Alcohol -based spray as placebo will be administrated before arterial puncture. Alcohol: Nurses will use an alcohol-based spray as placebo on patient's skin a few seconds before arterial puncture. Ethyl choride will be administrated before arterial puncture. Ethyl chloride: Nurses will administrate ethyl chloride vapocoolant spray on patient's skin a few seconds before arterial puncture.
    Measure Participants 60 66
    Median (Inter-Quartile Range) [scores on scale]
    2
    2

    Adverse Events

    Time Frame
    Adverse Event Reporting Description
    Arm/Group Title Control Ethyl Chloride
    Arm/Group Description Alcohol -based spray as placebo will be administrated before arterial puncture. Alcohol: Nurses will use an alcohol-based spray as placebo on patient's skin a few seconds before arterial puncture (of cubital arteria). Ethyl choride will be administrated before arterial puncture. Ethyl chloride: Nurses will administrate ethyl chloride vapocoolant spray on patient's skin a few seconds before arterial puncture (of cubital arteria).
    All Cause Mortality
    Control Ethyl Chloride
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total / (NaN) / (NaN)
    Serious Adverse Events
    Control Ethyl Chloride
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/60 (0%) 0/66 (0%)
    Other (Not Including Serious) Adverse Events
    Control Ethyl Chloride
    Affected / at Risk (%) # Events Affected / at Risk (%) # Events
    Total 0/60 (0%) 1/66 (1.5%)
    General disorders
    Dizziness after puncture 0/60 (0%) 1/66 (1.5%)
    Vascular disorders
    Local injury (ischaemia) 0/60 (0%) 0 0/66 (0%) 0

    Limitations/Caveats

    [Not Specified]

    More Information

    Certain Agreements

    Principal Investigators are NOT employed by the organization sponsoring the study.

    There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

    Results Point of Contact

    Name/Title Dr. Ballesteros-Peña
    Organization Servicio de Urgencias, Hospital de Basurto, Bilbao, España
    Phone (+34)946012804
    Email sendoa.ballesteros@ehu.eus
    Responsible Party:
    SENDOA BALLESTEROS-PEÑA, Emergency nurse practitioner, PhD doctor., Bionorte
    ClinicalTrials.gov Identifier:
    NCT02587143
    Other Study ID Numbers:
    • GASOHUB
    First Posted:
    Oct 27, 2015
    Last Update Posted:
    Jan 22, 2020
    Last Verified:
    Jan 1, 2020